Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Handbook of Obesity, Two-Volume Set -

Handbook of Obesity, Two-Volume Set

Media-Kombination
1212 Seiten
2024 | 5th edition
CRC Press
978-1-032-04712-6 (ISBN)
CHF 529,95 inkl. MwSt
  • Versand in 10-20 Tagen 
    (noch 5 im Versandlager)
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
This 2 volume set comprises of the 4th edition of Volume 1 and the 5th edition of Volume 2. Volume 1 covers the basic science aspects under the broad topic areas of epidemiology, etiology, and pathophysiology of obesity. Volume 2 spotlights on clinical applications for evaluation, diagnosis, prevention, and treatment of obesity.
This 2 volume set comprises of the 4th edition of Volume 1 and the 5th edition of Volume 2.

The fifth edition of Volume 1 of Handbook of Obesity written by global experts covers the basic science aspects under the broad topic areas of epidemiology, etiology, and pathophysiology of obesity. Divided into 5 sections and detailed in 66 chapters, this edition covers the important advances occurring over the past decades. With a focus on science of obesity and factors participating in the etiology of obesity, this topic is studied from biological, behavioural and environmental perspectives.

Volume 1 is structured into 5 parts:

Part 1 focuses on the history, definitions, and prevalence of the obesity. It identifies the historical references to excess weight, obesity in art and literature, direct and surrogate measurements of adiposity and obesity related traits, epidemiology of obesity around the globe, and age, sex and ethnic variation completes this part of the volume.

Part 2 explains the biological determinants of obesity. It explains the bioenergetics, energy dissipation mechanisms and exposure to experimental overfeeding, genetic and epigenetic evidence, metabolic rates, energy expenditure and energy partitioning, and the evidence on infections and adiposity.

Part 3 describes the behavioral determinants of obesity. It deals with chapters related to food, beverages, and ingestive behavior, dealing with smoking, breast-feeding, and sleep duration and pattern, and sedentary behavior, occupational work, and leisure-time physical activity and obesity.

Part 4 comprises of chapters explaining the environmental, social, and cultural determinants of obesity. The chapters in this section focus on the role of agriculture and the food industry in the current obesity epidemic, social and economic aspects of obesity, and ethnic and cultural differences and environmental pollutants.

Part 5 of this volume discusses the health consequences of obesity. The chapters address important topics such obesity and heart disease, lipoprotein metabolism, insulin resistance and diabetes, metabolic syndrome, cancer, hepatic biology, pulmonary functions, and arthritis and gout, mental health and quality of life, growth and health disorders in pediatric populations, and on bias and discrimination affecting the obese persons.

Volume 2 of the 5th Edition of the Handbook of Obesity spotlights on clinical applications for evaluation, diagnosis, prevention, and treatment of obesity. It covers on the several major developments occurred between the previous and the new edition, including the effect of SARS-CoV-2 on people with obesity, the concept of "Precision Medicine", and new medications approved by USFDA aiding patients with obesity weight loss of 15 to 20%.

This volume is structured into 5 parts:

Part 1 provides insights from evolution on changes in diet and physical activity, and the implications and results for preventing obesity, health care costs associated with obesity and the cost-effectiveness of obesity prevention and treatment.

Part 2 deals with evaluation of overweight patients, approaches for classifying obesity and using this knowledge to evaluate patients, and addressing ethnic and racial considerations in evaluating patients with obesity.

Part 3 explains the impact of lifestyle in managing obesity, which include behavioural management, diet, dietary composition, and meal timing, and the effects of physical activity and exercise in weight loss and weight loss maintenance.

Part 4 is focused on medications in the management of obesity. This includes drug selection, various classes of drugs, combination of drugs affecting weight loss, effect of herbal agents on weight loss and treatment of obesity in pediatric populations, genetic diseases causing obesity and the role of drugs in treating the dyslipidemias.

Part 5 discusses bariatric surgery, its history, procedure and effects in details, and other surgical techniques including electric stimulation of the vagus nerve, gastric balloons, intestinal liners and liposuction.

George A. Bray, MD, MACP, MACE, Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana, United States Claude Bouchard, PhD, Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana, United States Peter T. Katzmarzyk, PhD, FACSM, FTOS, FAHA, Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana, United States John P. Kirwan, PhD, Integrated Physiology and Molecular Medicine Laboratory, Pennington Biomedical Research Center, Baton Rouge, Louisiana, United States Leanne M. Redman, PhD, Reproductive Endocrinology and Women’s Health Laboratory, Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, Louisiana, United States Philip R. Schauer, MD, Metamor Institute, Pennington Biomedical Research Center, Baton Rouge, Louisiana

Volume One

Part 1 History, Definitions, and Prevalence

Chapter 1 From Hippocrates to the Obesity Society: A Brief History

Chapter 2 Obesity in Art and Literature

Chapter 3 Measurement of Total Adiposity, Regional Fat Depots, and Ectopic Fat

Chapter 4 Anthropometric Indicators of Adiposity in Relation to the Gold Standards

Chapter 5 Worldwide and Regional Prevalence of Obesity

Chapter 6 Age, Sex, Ethnicity, and Other Sources of Variation in the Prevalence of Obesity

Part 2 Biological Determinants of Obesity

Chapter 7 Bioenergetics and Obesity

Chapter 8 Mitochondrial Metabolic Inefficiencies in Skeletal Muscle: Implications for Obesity and Weight Loss

Chapter 9 Human Experimental Overfeeding

Chapter 10 Biology of Calorie Restriction and Intermittent Fasting

Chapter 11 Genetic Epidemiology and Obesity

Chapter 12 Genetic Variation and Obesity

Chapter 13 Single Gene Defects and Obesity

Chapter 14 Micro and Long RNAs as Regulators in Obesity

Chapter 15 Epigenetics and Obesity

Chapter 16 The Role of Adipocyte Precursors in Development and Obesity

Chapter 17 Small Animal Models of Obesity

Chapter 18 Obesity in Nonhuman Primates

Chapter 19 The Transcriptome, Proteome, and Metabolome of Obesity

Chapter 20 CNS Regulation of Energy Balance

Chapter 21 Gastrointestinal Regulation of Energy Balance

Chapter 22 Gut Microbiome and Obesity

Chapter 23 Sympathetic Nervous System and Obesity

Chapter 24 Hypothalamic-Pituitary Hormones and Obesity

Chapter 25 Brown, Beige, and White Adipocyte Development

Chapter 26 Adipose Tissue Metabolism, Adipokines, and Obesity

Chapter 27 Hepatic, Visceral, Pancreatic, and Cardiac Fat Deposition

Chapter 28 Skeletal Muscle Metabolism and Obesity

Chapter 29 Resting Metabolic Rate, Thermic Effect of Food, and Obesity

Chapter 30 Energy Cost of Exercise, Postexercise Metabolic Rates, and Obesity

Chapter 31 Energy Partitioning, Substrate Oxidation Rates, and Obesity

Chapter 32 COVID-19, Other Microbial Infections, and Obesity

Part 3 Behavioral Determinants of Obesity

Chapter 33 Obesity and Dietary Intake

Chapter 34 Beverages and Obesity: A Review of Current Scientific Evidence

Chapter 35 Obesity and Sedentary Time at Work and Home

Chapter 36 Leisure Time Physical Activity and Obesity

Chapter 37 Role of Early Life Nutrition & Breastfeeding on Obesity Development

Chapter 38 Tobacco Use, Marijuana Use, Vaping, and Obesity

Chapter 39 Sleep and Obesity

Chapter 40 Eating Disorders and Obesity

Part 4 Environmental, Social, and Cultural Determinants of Obesity

Chapter 41 The Role of the Food Industry in Obesity

Chapter 42 Transportation Policies and Obesity

Chapter 43 Urban Environment and Obesity

Chapter 44 Social and Economic Factors Related to Obesity Across the Globe

Chapter 45 Influence of Culture on Obesity

Chapter 46 Environmental Chemicals and Obesity

Part 5 Consequences of Obesity

Chapter 47 Obesity and Mortality

Chapter 48 Obesity and Heart Disease

Chapter 49 Obesity and Hypertension

Chapter 50 Obesity and Lipoprotein Metabolism

Chapter 51 Obesity and Insulin Resistance

Chapter 52 Obesity and Type 2 Diabetes

Chapter 53 Obesity and Metabolic Syndrome

Chapter 54 Obesity and Cancer

Chapter 55 Obesity and Inflammation

Chapter 56 Obesity, Gallbladder, and Gastrointestinal Diseases

Chapter 57 Obesity and Liver Diseases

Chapter 58 Obesity, Lung Function, and Lung Disease

Chapter 59 Obesity and Gout

Chapter 60 Obesity, Osteoarthritis, and Bone Disorders

Chapter 61 Obesity and Cognitive Decline

Chapter 62 Obesity, Mental Health, and Health-related Quality of Life

Chapter 63 Obesity and Reproductive Dysfunction

Chapter 64 Obesity in Pregnancy Complications and Outcomes

Chapter 65 Obesity, Growth, Development, Metabolic Disorder, and Insulin Resistance in Pediatrics

Chapter 66 Bias, Discrimination, and Obesity

Volume Two

Part 1 Prevention and Economic Outcomes of Obesity

Chapter 1 Dietary Changes in Human Evolution: Implications for the Prevention of Obesity

Chapter 2 Evolutionary Changes in Physical Activity, Diet, and Energy Expenditure: Implications for the Prevention of Obesity

Chapter 3 Prevention of Obesity in Adults

Chapter 4 The Prevention of Obesity in Children and Adolescents

Chapter 5 Re-engineering the Built Environment: Progress in Schools, Worksites, Neighborhoods, and Communities

Chapter 6 The Economic Costs of Obesity

Chapter 7 Cost-effectiveness of Obesity Prevention and Treatment

Chapter 8 Role of Government and Non-Government Organizations in the Obesity Pandemic and Its Prevention

Chapter 9 Role of Reimbursement in the Delivery of Treatment for Obesity in Adults and Children

Part 2 Evaluation of the Patients with Overweight or Obesity

Chapter 10 Classification, Evaluation, and Staging of the Patient with Obesity

Chapter 11 Indicators of Central Adiposity: A Critical Evaluation of Their Usefulness

Chapter 12 Genetic Obesity Syndromes

Chapter 13 Ethnic and Racial Considerations in the Evaluation of the Patient with Obesity

Part 3 Lifestyle in the Management of Obesity: Behavioral Modification, Diet, and Exercise

Chapter 14 Best Practices: Obesity and the Primary Care Providers

Chapter 15 In-person Behavioral Approaches for Weight Management

Chapter 16 Behavioral Interventions Delivered Remotely

Chapter 17 Cultural Considerations in Behavioral Therapy for Management of Obesity

Chapter 18 Diet Composition and Weight Loss: Is a Calorie a Calorie?

Chapter 19 Circadian Rhythms and Weight Loss: Timed Food Intake

Chapter 20 Comparison of Modern-Millennial Diets

Chapter 21 Dietary Energy Density and Its Contribution to Weight Control

Chapter 22 Dietary Patterns as a Basis for Diet Selection

Chapter 23 Physical Activity and Weight Loss: Volume, Intensity, and Mode

Chapter 24 Modifying Sedentary Behavior for the Prevention and Treatment of Obesity

Chapter 25 Preventing Weight Regain After Weight Loss

Chapter 26 Personalized and Precision Nutrition in the Management of Obesity: Can We Tailor the Treatment to the Patient?

Part 4 Medications in the Management of Obesity

Chapter 27 Drug-associated Weight Gain and Clinical Alternatives

Chapter 28 Mechanisms of Drug Action in Obesity

Chapter 29 Metabolic Effects of Progressive Weight Loss

Chapter 30 Older Drugs Used to Manage Obesity: Sympathomimetics and Orlistat

Chapter 31 Serotonergic Drugs for Treating Obesity

Chapter 32 Antidiabetic Drugs that Reduce Weight and Are Cardioprotective

Chapter 33 Approved Combination Agents: Phentermine/Topiramate

Chapter 34 Approved Combination Agents: Naltrexone-Bupropion

Chapter 35 Drugs That Affect Body Weight: The Glucagon-like Peptide-1 Agonists

Chapter 36 Hydrogels in the Treatment of Obesity

Chapter 37 Dual and Triple-Action Peptides

Chapter 38 Antiobesity Medications on the Horizon

Chapter 39 Treatments for Rare Forms of Genetic Obesity

Chapter 40 Special Issues in Using Medications in Children & Adolescents

Chapter 41 Dietary Supplements and Weight Management

Part 5 Surgical Interventions for Obesity

Chapter 42 Historical Overview of Metabolic and Bariatric Surgery

Chapter 43 Overview: Current Metabolic Operations and Long-term Outcomes

Chapter 44 Effects of Metabolic Surgery on Type 2 Diabetes

Chapter 45 Cardiovascular Outcomes in Metabolic Surgery

Chapter 46 Effect of Bariatric Surgery on Cancer

Chapter 47 Bariatric Surgery in Pediatric Patients

Chapter 48 Other Bariatric Procedures: Nerve Stimulation, Gastric Balloons, Intestinal Liners, and Others

Erscheint lt. Verlag 9.1.2024
Zusatzinfo 172 Tables, black and white; 187 Line drawings, color; 118 Line drawings, black and white; 37 Halftones, color; 15 Halftones, black and white; 224 Illustrations, color; 133 Illustrations, black and white
Verlagsort London
Sprache englisch
Maße 210 x 280 mm
Gewicht 2400 g
Themenwelt Medizin / Pharmazie Gesundheitsfachberufe Diätassistenz / Ernährungsberatung
Medizinische Fachgebiete Innere Medizin Diabetologie
Medizinische Fachgebiete Innere Medizin Endokrinologie
Medizinische Fachgebiete Innere Medizin Kardiologie / Angiologie
Studium 1. Studienabschnitt (Vorklinik) Biochemie / Molekularbiologie
Naturwissenschaften Biologie
ISBN-10 1-032-04712-7 / 1032047127
ISBN-13 978-1-032-04712-6 / 9781032047126
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Wie bewerten Sie den Artikel?
Bitte geben Sie Ihre Bewertung ein:
Bitte geben Sie Daten ein: